Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer
Jeffrey H. Hager, Danielle B. Ulanet, Lothar Hennighausen et al. · 2009
Read Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer by Jeffrey H. Hager, Danielle B. Ulanet, Lothar Hennighausen et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004455.txt.
Description
Blocking a survival protein made pancreatic tumors less invasive in mice, report Jeffrey Hager, Danielle Ulanet, Lothar Hennighausen, and co-authors in PLOS ONE in 2009. Cells die by a built-in program that members of the Bcl-2 family control. Tumors often raise the levels of family members that block death, which helps them survive.
The protein studied here is Bcl-x, one of those death blockers. The team removed it genetically in a mouse model of pancreatic neuroendocrine cancer. Surprisingly, tumor growth and cell death barely changed, but the tumors became much less invasive, as the title reports. That split result matters: a drug target need not shrink a tumor to be useful if it stops the tumor from spreading into new tissue.
Catalog record
| CREATOR | Jeffrey H. Hager, Danielle B. Ulanet, Lothar Hennighausen et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004455